First-in-human study to assess the safety, tolerability and pharmacokinetics following single-dose administration of ABT-981 in Healthy Subjects.

Trial Profile

First-in-human study to assess the safety, tolerability and pharmacokinetics following single-dose administration of ABT-981 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Mar 2017

At a glance

  • Drugs ABT 981 (Primary) ; ABT 981 (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors AbbVie
  • Most Recent Events

    • 18 Mar 2017 Results (n=78) from this and one other phase 1 study presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 06 May 2016 Results from this trial and other trial (see trial - 222237) published in the Journal of Clinical Pharmacology
    • 01 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top